Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

The Good and Bad of MRI Evaluation of the Urothelial Tract

December 13, 2016 By American Roentgen Ray Society

When performed properly, MR urography (MRU) can be an alternative to CT urography (CTU) for imaging of the entire urinary tract. Some radiologists may prefer MRU for pediatric populations, patients undergoing repeat examinations, and individuals with compromised renal functions.

However, MRU can be a challenging examination to perform and interpret; therefore, a team of researchers published a study outlining the pitfalls along with potential methods of correcting, detecting, or avoiding them. The information is discussed in the study, “MRI Evaluation of the Urothelial Tract: Pitfalls and Solutions,” published in the December 2016 issue of the American Journal of Roentgenology (AJR). It is available through open accessible on the AJR website located here.

(Credit: Getty Images)

“Meticulous attention to detail is required to optimize the imaging quality of MRU, and in our experience, this can be more problematic to achieve with MRU than with CTU,” said study coauthor Nicola Schieda, a radiologist with the Department of Medical Imaging, The Ottawa Hospital, Ontario. “When using the MRU examination, steps must be taken to ensure adequate distention of the collecting system and dilution of excreted gadolinium. It is important to recognize normal physiologic characteristics and expected findings on various pulse sequences, especially to avoid misinterpretation of strictures related to urinary peristalsis, filling defects related to flow-related artifacts, gadolinium mimicking urothelial hemorrhage, or hemorrhage mimicking tumor. Adequate visualization and evaluation of the entire urinary tract is critical because urothelial carcinoma frequently presents with synchronous or metachronous lesions.”

Common indications for MRU include, but are not limited to, investigation of the cause of urinary obstruction, evaluation of urothelial neoplasms, and characterization of complex congenital anomalies of the urinary system.

A potential advantage of using MRU rather than CTU is related to the role of MRI in quantitative tumor characterization, the study said. In particular, apparent diffusion coefficient values obtained from diffused weighted imaging may help prospectively predict tumor invasive or proliferative potential, which may affect management decisions.

The study was based on the authors’ experience with MR Urography and an extensive review of the literature on the topic.

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech